Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis.
To study the relation of 14-3-3 sigma gene promoter hypermethylation and its transcription expression levels in sporadic breast carcinogenesis. Methylation of 14-3-3 sigma gene was detected by sensitive MSP assay in carcinous, non-cancerous, and normal tissue, and its mRNA was also detected by real time PCR based on SYBR Green 1 as well, and protein was detected by west blotting assay. The methylation frequencies of 14-3-3 sigma were 90% in 68 cases of sporadic breast cancer patients. Methylation was presented in portions (2/13, 18%) of hyperplastic samples, and no hypermethylation was presented in normal tissue. The methylation change of 14-3-3 sigma gene was markedly related with various types, grades, and lymph node metastases (P < 0.05), and no significant differences in methylation frequencies were seen between premenopause and postmenopause (P > 0.05). The methylation of 14-3-3 sigma shows reverse relation with its mRNA transcription and expression level (P < 0.05). Only was lymph node metastases strongly associated with poor outcome (P = 0.02). Whether 14-3-3 sigma promoter methylation or not did not affect the 5 years survival rate of sporadic breast cancer patients (P > 0.05). Epigenetics alterations of the 14-3-3 sigma can contribute to reducing or losing expression of 14-3-3 sigma protein, which play an important role in the development of sporadic breast carcinomas and involved in various types, grades, and lymph node metastases. Otherwise, node metastases of breast carcinogenesis patients are strongly associated with poor outcome.
Luo
Jie
J
The Neurosurgery Department, Taihe Hospital, Yunyang Medicinal College, Shiyan, Hubei, 442000, China.
Feng
Jing
J
Lu
Jun
J
Wang
Yuping
Y
Tang
Xuanbin
X
Xie
Fei
F
Li
Wenbin
W
D048948:14-3-3 Proteins / Q000096:biosynthesis / Q000235:genetics* / Q000502:physiology; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000096:biosynthesis / Q000235:genetics* / Q000502:physiology; D001943:Breast Neoplasms / Q000737:chemistry / Q000208:ethnology / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002277:Carcinoma / Q000737:chemistry / Q000208:ethnology / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D002681:China / Q000453:epidemiology; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000032:analysis*; D004847:Epithelial Cells / Q000378:metabolism; D005092:Exonucleases / Q000096:biosynthesis / Q000235:genetics* / Q000502:physiology; D005095:Exoribonucleases; D005260:Female; D005348:Fibrocystic Breast Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D020868:Gene Silencing; D006801:Humans; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics* / Q000502:physiology; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012333:RNA, Messenger / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis
D048948:14-3-3 Proteins; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D005092:Exonucleases; D005095:Exoribonucleases; C413442:SFN protein, human
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6049-54
10811911
DNA Cell Biol. 2005 Apr;24(4):264-9
15812243
Surg Oncol Clin N Am. 1999 Oct;8(4):657-72, vi
10452933
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6
8790415
Cancer Res. 2006 Mar 15;66(6):3096-105
16540659
Nature. 1999 Oct 7;401(6753):616-20
10524633
Oncogene. 2000 Nov 2;19(46):5298-302
11077447
Cell Res. 2005 Apr;15(4):237-46
15857578
Mol Cell. 1997 Dec;1(1):3-11
9659898
J Clin Oncol. 2005 Dec 20;23(36):9105-12
16361617
Am J Pathol. 2002 Feb;160(2):605-12
11839581
Biotechniques. 1998 Jun;24(6):954-8, 960, 962
9631186
J Histochem Cytochem. 2005 May;53(5):621-9
15872055
Mol Cell Proteomics. 2005 Apr;4(4):555-69
15644556
J Virol. 2005 Mar;79(5):2780-7
15708996
Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):165-9
12582028
Oncogene. 2001 Jun 7;20(26):3348-53
11423985
Bioessays. 2000 Aug;22(8):728-37
10918303